Navigation Links
Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups

CHAPEL HILL, N.C., March 11 /PRNewswire/ -- With patent expiration a looming concern across the bio-pharmaceutical industry, new product commercialization efforts have taken on increased importance. It's against this backdrop that new product planning groups across biopharma are trying to deal more effectively with the twin pressures of meeting timelines and delivering commercial insights.

A recent data-rich benchmarking study from Best Practices, LLC delivers actionable insights on the critical elements of the new product planning (NPP) function. The study, "Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability," identifies the full set of activities that NPP groups perform across the development cycle as well as the structure and roles of NPP groups.

To download a complimentary study excerpt, go to:

The research project illustrated that as companies move through each successive development Phase, the actual nature of assessment activities changes. For instance, many companies stated that competitive assessments and lifecycle planning made in the early stages are somewhat speculative, primarily designed to spot opportunities. Later on these activities become more specific, designed to drive forecasts.

While most companies perform competitive assessments from pre-clinical all the way through Phase 3, study participants said the activity is particularly critical in pre-clinical because:

  • It can gauge what changes will occur in the years ahead
  • It helps with understanding the disease state and where competitors' products fit in
  • It informs how well your drug will fit in the market
  • It helps frame "go, no-go" analysis so that, as data comes in, competitive assessment can drive forecasting and profitability potential
  • The research examines dozens of NPP developmental activities in terms of timing during the development process, intended outcomes and value for the organization.

In addition, the study details the strengths and weaknesses of various NPP organizational structures and how the operational characteristics of the NPP function evolve as a company matures.

To review samples of key metrics and findings in the report, download a complimentary study excerpt at:

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at best-in-class organizations such as Abbott, Astellas, Bayer, Daiichi Sankyo, Eli Lilly, Merck, Novartis, sanofi aventis, Wyeth and others.

To learn more about Best Practices' other timely research visit: or contact Jeff Zimmer at 919-767-9180 or


Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 

SOURCE Best Practices, LLC

Back to top



SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AdMeTech Hails New Research That Shows Promise of MRI to Discriminate Aggressive Prostate Cancer From Dormant Disease
2. Massachusetts Institute of Technology (MIT) to Launch New Brain Research Effort with Acquisition of Elekta MEG Technology
3. Americas Pharmaceutical Research and Biotechnology Companies Lead the Charge Toward Longer, Healthier Lives for Americans
4. AdMeTech Calls for Major Research Commitment to End Prostate Cancer Crisis
5. Researchers Pave Way for Tracking of Prostate Motion With a Single kV Imager During Arc Radiotherapy
6. BNA Books Announces Publication of New 2009 Cumulative Supplement to Pharmaceutical Law: Regulation of Research, Development, and Marketing
7. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
8. AdMeTech to Testify in Congress About Prostate Cancer Crisis, Research to Improve Diagnostic Tools as a Solution
9. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
10. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
11. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
Post Your Comments:
(Date:10/12/2015)... Leadership of the National Association of Vision Care ... Aspasia Shappet , CEO of MESVision resumed her role as ... at its annual strategic planning meeting in Chicago ... the organization from May 2013 to May of this year. ... a result of the increased demands of his recent appointment ...
(Date:10/12/2015)... , Oct. 12, 2015 A new computer ... children can predict whether they will develop effective language ... to a study in the journal Brain and ... --> In the journal,s Oct. 12 online edition, ... computer program determines how specific regions of the brain ...
(Date:10/12/2015)... ) ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Industry Trends, Technologies, Participants, and Environment" ... ) has announced the addition of ... Companion Diagnostic Market to 2019 - Strategic ...
Breaking Medicine Technology:
(Date:10/12/2015)... Grove Village, IL, USA (PRWEB) , ... October ... ... solutions and high-fidelity personal audio products, will present the latest version of Companion ... insert earphones for audiometry, at the European Union of Hearing Aid Acousticians’ (EUHA) ...
(Date:10/12/2015)... ... October 12, 2015 , ... FEI Behavioral Health, ... from EAP to crisis management, will present a session at the Wisconsin Society ... 14-16, 2015. , FEI’s Chief Operating Officer Daniel Potterton will present an informative ...
(Date:10/12/2015)... FL (PRWEB) , ... October 12, 2015 , ... ... Awareness Month, IQ Formulations today announced its charitable donation to the National Breast ... inspiring hope in those affected by breast cancer through early detection, education, and ...
(Date:10/12/2015)... ... October 12, 2015 , ... SQM Group is proud ... contact channel benchmarking study. Be a part of this insightful and leading-edge ... customer experience, customer journey, contact channel execution and intelligence, workforce optimization, and tools ...
(Date:10/12/2015)... ... October 12, 2015 , ... Holcomb – Kreithen Plastic ... in Florida, announced today that it will host “Plastic Surgery University,” an educational series ... Town Center (“UTC Mall”) in Sarasota, FL on Saturday, October 24, 2015. , ...
Breaking Medicine News(10 mins):